207 related articles for article (PubMed ID: 32205118)
1. Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo.
Desaphy JF; Farinato A; Altamura C; De Bellis M; Imbrici P; Tarantino N; Caccia C; Melloni E; Padoani G; Vailati S; Keywood C; Carratù MR; De Luca A; Conte D; Pierno S
Exp Neurol; 2020 Jun; 328():113287. PubMed ID: 32205118
[TBL] [Abstract][Full Text] [Related]
2. Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity.
De Bellis M; Carbonara R; Roussel J; Farinato A; Massari A; Pierno S; Muraglia M; Corbo F; Franchini C; Carratù MR; De Luca A; Conte Camerino D; Desaphy JF
Neuropharmacology; 2017 Feb; 113(Pt A):206-216. PubMed ID: 27743929
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs.
Desaphy JF; Carbonara R; Costanza T; Conte Camerino D
Exp Neurol; 2014 May; 255(100):96-102. PubMed ID: 24613829
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of antimyotonic efficacy of β-adrenergic drugs in a rat model of myotonia.
Desaphy JF; Costanza T; Carbonara R; Conte Camerino D
Neuropharmacology; 2013 Feb; 65():21-7. PubMed ID: 23000075
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants of state-dependent block of voltage-gated sodium channels by pilsicainide.
Desaphy JF; Dipalma A; Costanza T; Bruno C; Lentini G; Franchini C; George A; Conte Camerino D
Br J Pharmacol; 2010 Jul; 160(6):1521-33. PubMed ID: 20590641
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate.
Farinato A; Altamura C; Imbrici P; Maggi L; Bernasconi P; Mantegazza R; Pasquali L; Siciliano G; Lo Monaco M; Vial C; Sternberg D; Carratù MR; Conte D; Desaphy JF
Pharmacol Res; 2019 Mar; 141():224-235. PubMed ID: 30611854
[TBL] [Abstract][Full Text] [Related]
7. Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block.
Desaphy JF; De Luca A; Didonna MP; George AL; Camerino Conte D
J Physiol; 2004 Jan; 554(Pt 2):321-34. PubMed ID: 14608015
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers.
De Luca A; Natuzzi F; Lentini G; Franchini C; Tortorella V; Conte Camerino D
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):653-61. PubMed ID: 9053738
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of a human skeletal myotonia produced by mutation in the C-terminus of NaV1.4: is Ca2+ regulation defective?
Biswas S; DiSilvestre DA; Dong P; Tomaselli GF
PLoS One; 2013; 8(12):e81063. PubMed ID: 24324661
[TBL] [Abstract][Full Text] [Related]
10. Blockers of Skeletal Muscle Na
De Bellis M; Boccanegra B; Cerchiara AG; Imbrici P; De Luca A
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614292
[TBL] [Abstract][Full Text] [Related]
11. Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+ channels.
Wang GK; Russell C; Wang SY
J Physiol; 2004 Feb; 554(Pt 3):621-33. PubMed ID: 14608007
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the antimyotonic activity of mexiletine and some new analogs on sodium currents of single muscle fibers and on the abnormal excitability of the myotonic ADR mouse.
De Luca A; Pierno S; Natuzzi F; Franchini C; Duranti A; Lentini G; Tortorella V; Jockusch H; Camerino DC
J Pharmacol Exp Ther; 1997 Jul; 282(1):93-100. PubMed ID: 9223544
[TBL] [Abstract][Full Text] [Related]
13. Molecular dissection of lubeluzole use-dependent block of voltage-gated sodium channels discloses new therapeutic potentials.
Desaphy JF; Carbonara R; Costanza T; Lentini G; Cavalluzzi MM; Bruno C; Franchini C; Camerino DC
Mol Pharmacol; 2013 Feb; 83(2):406-15. PubMed ID: 23175529
[TBL] [Abstract][Full Text] [Related]
14. Increased hindrance on the chiral carbon atom of mexiletine enhances the block of rat skeletal muscle Na+ channels in a model of myotonia induced by ATX.
Desaphy JF; Conte Camerino D; Franchini C; Lentini G; Tortorella V; De Luca A
Br J Pharmacol; 1999 Nov; 128(6):1165-74. PubMed ID: 10578128
[TBL] [Abstract][Full Text] [Related]
15. Chimeric agents derived from the functionalized amino acid, lacosamide, and the α-aminoamide, safinamide: evaluation of their inhibitory actions on voltage-gated sodium channels, and antiseizure and antinociception activities and comparison with lacosamide and safinamide.
Park KD; Yang XF; Dustrude ET; Wang Y; Ripsch MS; White FA; Khanna R; Kohn H
ACS Chem Neurosci; 2015 Feb; 6(2):316-30. PubMed ID: 25418676
[TBL] [Abstract][Full Text] [Related]
16. Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia.
Morari M; Brugnoli A; Pisanò CA; Novello S; Caccia C; Melloni E; Padoani G; Vailati S; Sardina M
J Pharmacol Exp Ther; 2018 Feb; 364(2):198-206. PubMed ID: 29167350
[TBL] [Abstract][Full Text] [Related]
17. Effect of mexiletine on sea anemone toxin-induced non-inactivating sodium channels of rat skeletal muscle: a model of sodium channel myotonia.
Desaphy JF; Camerino DC; Tortorella V; De Luca A
Neuromuscul Disord; 1999 May; 9(3):182-9. PubMed ID: 10382914
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of frog skeletal muscle sodium channels by newly synthesized chiral derivatives of mexiletine and tocainide.
De Luca A; Natuzzi F; Falcone G; Duranti A; Lentini G; Franchini C; Tortorella V; Camerino DC
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):777-87. PubMed ID: 9453464
[TBL] [Abstract][Full Text] [Related]
19. Molecular Insights into the Local Anesthetic Receptor within Voltage-Gated Sodium Channels Using Hydroxylated Analogs of Mexiletine.
Desaphy JF; Dipalma A; Costanza T; Carbonara R; Dinardo MM; Catalano A; Carocci A; Lentini G; Franchini C; Camerino DC
Front Pharmacol; 2012; 3():17. PubMed ID: 22403541
[TBL] [Abstract][Full Text] [Related]
20. Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia.
Gardoni F; Morari M; Kulisevsky J; Brugnoli A; Novello S; Pisanò CA; Caccia C; Mellone M; Melloni E; Padoani G; Sosti V; Vailati S; Keywood C
J Pharmacol Exp Ther; 2018 Dec; 367(3):442-451. PubMed ID: 30291173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
